ons in diabetes, obesity and Novo Nordisk ® y care DKK billion #1 80% 100 Haemophilia #3 50% 60% 40% lue: 5.2% 20% value 0% Feb 2021 e market share (RHS) market position 80 40% 60 30% 40 20% 20 CAGR 3 value: 3.0% 10% 0 FY 2016 Market value 0% FY 2020 NN value market share (RHS) Global market position passing agents segment. Recombinant and plasma derived products on list prices in the US.
Download PDF file